{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:04:32Z","timestamp":1776481472048,"version":"3.51.2"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":568,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CAPES Brazilian","award":["474136\/2007-8"],"award-info":[{"award-number":["474136\/2007-8"]}]},{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias Farmac\u00eauticas (PPGCF-UFRGS)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.pnpbp.2011.08.015","type":"journal-article","created":{"date-parts":[[2011,8,27]],"date-time":"2011-08-27T05:53:26Z","timestamp":1314424406000},"page":"101-109","source":"Crossref","is-referenced-by-count":47,"title":["Antidepressant-like effect of Valeriana glechomifolia Meyer (Valerianaceae) in mice"],"prefix":"10.1016","volume":"36","author":[{"given":"Liz G.","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa A.","family":"Salles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andresa H.","family":"Betti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satchie","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Cassel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubem Figueir\u00f3","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilsane L.","family":"von Poser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stela M.K.","family":"Rates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2011.08.015_bb0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0305-1978(97)00121-X","article-title":"Phylogenetic implications of an expanded valepotriate distribution in the Valerianaceae","volume":"26","author":"Backlund","year":"1998","journal-title":"Biochem Syst Ecol"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0091-3057(01)00599-8","article-title":"Intra and interstrain differences in models of \u201cbehavioral despair\u201d","volume":"70","author":"Bai","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"issue":"125","key":"10.1016\/j.pnpbp.2011.08.015_bb0015","first-page":"2079","article-title":"Pharmacotherapy of depression: recent developments","volume":"3","author":"Baumann","year":"2007","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0025","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1055\/s-0030-1271084","article-title":"In vitro effect of valepotriates isolated from Valeriana glechomifolia on rat P-type ATPases","volume":"77","author":"Bettero","year":"2011","journal-title":"Planta Med"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0030","first-page":"36","article-title":"Initial exploratory observational pharmacology of Valeriana wallichii on stress management: a clinical report","volume":"9","author":"Bhattacharyya","year":"2007","journal-title":"Nepal Med Coll J"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0035","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/s-2007-969834","article-title":"The action of valepotriates on the synthesis of DNA and proteins of cultured hepatoma cells","volume":"49","author":"Bounthanh","year":"1983","journal-title":"Planta Med"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbr.2005.06.015","article-title":"A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests","volume":"164","author":"Bourin","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0045","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0924-977X(02)00057-3","article-title":"The role of noradrenaline and noradrenaline reuptake inhibitors in depression","volume":"12","author":"Brunello","year":"2002","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0050","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jfoodeng.2010.05.015","article-title":"Supercritical fluid extraction of alkaloids from Ilex paraguariensis St. Hill","volume":"100","author":"Cassel","year":"2010","journal-title":"J Food Eng"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0055","first-page":"753","article-title":"In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAA receptor in rat brain","volume":"45","author":"Cavadas","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0014-2999(00)00566-5","article-title":"The role of dopamine in the mechanism of action of antidepressant drugs","volume":"405","author":"D'Aquila","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0075","article-title":"The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects","author":"Dell'Osso","year":"2010","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0080","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.pnpbp.2007.08.042","article-title":"Evidence for the involvement of the monoaminergic system in the antidepressant-like action of two 4-amine derivatives of 10, 11-dihydro-5H-dibenzo [a, d] cycloheptane in mice evaluated in the tail suspension test","volume":"32","author":"Duarte","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0085","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","article-title":"The role of dopamine in the pathophysiology of depression","volume":"64","author":"Dunlop","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0006-3223(94)00201-D","article-title":"The Na+K+ ATPase hypothesis for bipolar illness","volume":"37","author":"El-Mallakh","year":"1995","journal-title":"Biol Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2011.08.015_bb0095","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.2042-7158.2010.01146.x","article-title":"Vasorelaxant effect of Valeriana edulis ssp. procera (Valerianaceae) and its mode of action as calcium channel blocker","volume":"62","author":"Estrada-Soto","year":"2010","journal-title":"J Pharm Pharmacol"},{"issue":"suppl 1","key":"10.1016\/j.pnpbp.2011.08.015_bb0100","first-page":"26","article-title":"New approaches to the treatment of refractory depression","volume":"61","author":"Fava","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biopsych.2006.05.031","article-title":"Dopamine D2-like receptors and the antidepressant response","volume":"61","author":"Gherson","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0110","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.4088\/JCP.v64n1211","article-title":"The economic burden of depression in the United States: how did it change between 1990 and 2000?","volume":"64","author":"Greenberg","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.phymed.2007.11.027","article-title":"Extracts of Valeriana officinalis L. s.l. show anxiolitic and antidepressant effects but neither sedative nor myorelaxant properties","volume":"15","author":"Hattesohl","year":"2008","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0120","first-page":"274","article-title":"Antispasmodic effects of valeriana compounds: an in vivo and in vitro study on the guinea-pig ileum","volume":"257","author":"Hazelholff","year":"1982","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0125","doi-asserted-by":"crossref","unstructured":"Holzmann I, Filho VC, Mora TC, C\u00e1ceres A, Mart\u00ednez JV, Cruz SM, et al. Evaluation of behavioral and pharmacological effects of hydroalcoholic extract of Valeriana prionophylla Standl. from Guatemala. eCAM in press. doi:10.1155\/2011\/312320.","DOI":"10.1155\/2011\/312320"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0130","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pnpbp.2009.11.023","article-title":"Evidence of the serotonergic 5-HT2A\/2C and 5-HT3 receptors in the antidepressant-like effect caused by oral administration of bis selenide in mice","volume":"34","author":"Jesse","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pnpbp.2009.11.015","article-title":"Antidepressant-like effect of the methanolic extract from Bupleurum falcatum in the tail suspension test","volume":"34","author":"Kwon","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bcp.2006.09.029","article-title":"Interaction of valerian extracts of different polarity with adenosine receptors: identification of isovaltrate as an inverse agonist at A1 receptors","volume":"73","author":"Lacher","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0145","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4088\/JCP.v63n0805","article-title":"Combining antidepressants for treatment resistant depression: a review","volume":"63","author":"Lam","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0150","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archpsyc.57.8.787","article-title":"Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders","volume":"57","author":"Lambert","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0155","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1021\/np800716f","article-title":"Acylated iridoids with cytotoxicity from Valeriana jatamansi","volume":"72","author":"Lin","year":"2009","journal-title":"J Nat Prod"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0160","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0091-3057(03)00121-7","article-title":"6-Methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS","volume":"75","author":"Marder","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0165","article-title":"A valepotriate fraction of Valeriana glechomifolia shows sedative and anxiolytic properties and impairs recognition but not aversive memory in mice","author":"Maurmann","year":"2009","journal-title":"eCAM"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0170","first-page":"291","article-title":"In vitro study on the interaction of extracts and pure compounds from Valeriana officinalis roots with GABA, benzodiazepine and barbiturate receptors in rat brain","volume":"64","author":"Mennini","year":"1993","journal-title":"Fitoterapia"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0175","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.phymed.2009.10.020","article-title":"Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats","volume":"17","author":"Murphy","year":"2010","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0185","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.bmc.2010.01.040","article-title":"Searching for multi-target antipsychotics: discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors","volume":"18","author":"Neves","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0190","first-page":"4","article-title":"Relationship of neurotransmitters to the symptoms of major depressive disorder","volume":"69","author":"Nutt","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0195","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0893-133X(00)00196-2","article-title":"Role of 5-HT1A and 5-HT1B receptors in the mediation of behavior in the forced swim test in mice","volume":"24","author":"O'Neill","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0200","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1023\/A:1022576405534","article-title":"Effects of Valeriana officinalis extracts on [3H]Flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release","volume":"24","author":"Ortiz","year":"2004","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0205","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0165-0327(00)00270-6","article-title":"Melatonin response to clonidine administration in depression: indication of presynaptic alpha2-adrenoceptor dysfunction","volume":"65","author":"Paparrigopoulos","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0210","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S1353-8020(09)70841-7","article-title":"Dopamine receptor agonists and depression in Parkinson's disease","volume":"15","author":"Picillo","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"10.1016\/j.pnpbp.2011.08.015_bb0215","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.pnpbp.2011.03.005","article-title":"Mechanisms of antidepressant action: an integrated dopaminergic perspective","volume":"35","author":"Porcelli","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0220","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0225","series-title":"Animal models in psychopharmacology","first-page":"137","article-title":"Pharmacological models of depression","author":"Porsolt","year":"1991"},{"issue":"12","key":"10.1016\/j.pnpbp.2011.08.015_bb0230","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.4088\/JCP.v67n1203","article-title":"Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review","volume":"67","author":"Ruh\u00e9","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.08.015_bb0235","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jep.2011.02.018","article-title":"Antidepressant effect of Valeriana wallichii patchouli alcohol chemotype in mice: behavioural and biochemical evidence","volume":"135","author":"Sah","year":"2011","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0245","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jpsychires.2009.06.003","article-title":"Adjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepines","volume":"44","author":"Sarris","year":"2010","journal-title":"J Psychiatr Res"},{"issue":"2","key":"10.1016\/j.pnpbp.2011.08.015_bb0250","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bbr.2010.02.042","article-title":"Effect of non-selective dopaminergic receptor agonist on disrupted maternal behavior in olfactory bulbectomized mice","volume":"210","author":"Sato","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0255","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1055\/s-2002-32544","article-title":"Quantitative determination of valepotriates from Valeriana native to south Brazil","volume":"68","author":"Silva","year":"2002","journal-title":"Planta Med"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0260","series-title":"Essential psychopharmacology \u2014 neuroscientific basis and practical applications","author":"Stahl","year":"2008"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0265","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0270","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/ptr.2980","article-title":"Terpenoid content of Valeriana wallichii extracts and antidepressant-like response profiles","volume":"24","author":"Subhan","year":"2010","journal-title":"Phytother Res"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0275","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0378-8741(94)90055-8","article-title":"Effects of a prolonged administration of valepotriates in rats on the mothers and their offspring","volume":"41","author":"Tufik","year":"1994","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0280","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.neuropharm.2005.06.002","article-title":"The antidepressant-like effect of Hypericum caprifoliatum Cham & Schlecht (Guttiferae) on forced swimming test results from an inhibition of neuronal monoamine uptake","volume":"49","author":"Viana","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0285","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2007.08.045","article-title":"The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors","volume":"578","author":"Wang","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0290","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/157019310791065537","article-title":"Chemical constituents of plants from the genus Valeriana","volume":"7","author":"Wang","year":"2010","journal-title":"Mini-Rev Org Chem"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0295","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1590\/S0100-879X2001001000005","article-title":"In vivo and in vitro effect of imipramine and fluoxetine on Na+K+ATPase activity in synaptic plasma membranes from the cerebral cortex of rats","volume":"34","author":"Zanatta","year":"2001","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.pnpbp.2011.08.015_bb0300","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/npp.2008.184","article-title":"Postsynaptic \u03b1-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior","volume":"34","author":"Zhang","year":"2009","journal-title":"Neuropsychopharmacology"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611002624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611002624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T02:10:05Z","timestamp":1638411005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584611002624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0278584611002624"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.08.015","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}